Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTPγS binding

Life Sciences

Volumn 65, Issue 16, 1999, Pages 1633-1645

  Geurts, Muriel ^a   Hermans, Emmanuel ^a   Maloteaux, Jean Marie ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

35S GTP S binding; D1 dopamine receptor; D2 dopamine receptor; G protein; Spiperone; Striatal membranes

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BROMOCRIPTINE; CLOZAPINE; DOMPERIDONE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOPERIDOL; KETANSERIN TARTRATE; PERGOLIDE; PHENTOLAMINE MESYLATE; PROPYLNORAPOMORPHINE; SPIPERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; MALE; MEMBRANE BINDING; NONHUMAN; PROTEIN BINDING; RAT; RECEPTOR BINDING; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; BENZAZEPINES; BINDING SITES; CORPUS STRIATUM; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUANOSINE DIPHOSPHATE; KINETICS; MALE; MEMBRANES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SUBSTRATE SPECIFICITY; SULFUR RADIOISOTOPES;

ANIMALIA;

EID: 0033543766     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00412-9     Document Type: Article

References (51)

1. C.W. Taylor, Biochem. J. 272 1-13 (1990).
2. Y. Odagaki and K. Fuxe, Methods in Molecular Biology, Vol. 83 : Receptor Signal Transduction Protocols, R.A.J. Challiss (Ed), 133-141, Humana Press, Totowa (1997).
3. J.-L. Yue, H. Ueda and Y. Misu, Life Sci. 54 PL 413-418 (1994).
4. P. Onali and M.C. Olianas, Biochem. Pharmacol. 36 2839-2845 (1987).
5. Y. Odagaki and K. Fuxe, Biochem. Pharmacol. 50 325-335 (1995).
6. Y. Odagaki, N. Nishi and T. Koyama, Life Sci. 62 1537-1541 (1998).
7. S. Lazareno, T. Farries and N.J.M. Birdsall, Life Sci. 52 449-456 (1993).
8. A. Lorenzen, M. Fuss, H. Vogt and U. Schwabe, Mol. Pharmacol. 44 115-123 (1993).
9. L.J. Sim, D.E. Selley and S.R. Childers, Methods in Molecular Biology, Vol. 83 : Receptor Signal Transduction Protocols, R.A.J. Challiss (Ed), 117-132, Humana Press, Totowa (1997).
10. B. Gardner, D.A. Hall and P.G. Strange, Br. J. Pharmacol. 118 1544-1550 (1996).
11. B. Gardner, D.A. Hall and P.G. Strange, J. Neurochem. 69 2589-2598 (1997).
12. B. Gardner and P.G. Strange, Br. J. Pharmacol. 124 978-984 (1998).
13. B.L. Wiens, C.S. Nelson and K.A. Neve, Mol. Pharmacol. 54 435-444 (1998).
14. C. Chabert, C. Cavegn, A. Bernard and A. Mills, J. Neurochem. 63 62-65 (1994).
15. A. Malmberg, A. Mikaels and N. Mohell, J. Pharmacol. Exp. Ther. 285 119-126 (1998).
16. Z. Elazar, G. Siegel and S. Fuchs, Embo J. 8 2353-2357 (1989).
17. S.E. Senogles, A.M. Spiegel, E. Padrell, R. Iyengar and M.G. Caron, J. Biol. Chem. 265 4507-4514 (1990).
18. E. Friedman, P. Butkerait and H.-Y. Wang, Anal. Biochem. 214 171-178 (1993).
19. E. Friedman, E. Yadin and H.-Y. Wang, Neuroscience 70 739-747 (1996).
20. J.W. Kebabian and D.B. Calne, Nature 277 93-96 (1979).
21. H.-Y. Wang, A.S. Undie and E. Friedman, Mol. Pharmacol. 48 988-994 (1995).
22. O. Civelli, J.R. Bunzow and D.K. Grand Y, Annu. Rev. Pharmacol. Toxicol. 32 281- 307 (1993).
23. A.I. Levey, S.M. Hersch, D.B. Rye, R.K. Sunahara, H.B. Niznik, C.A. Kitt, D.L. Price, R. Maggio, M.R. Brann, B.J. Ciliax, Proc. Natl. Acad. Sci. USA 90 8861-8865 (1993).
24. D. Levesque, J. Diaz, C. Pilon, M.P. Martres, B. Giros, E. Souil, D. Schott, J.L. Morgat, J.C. Schwartz and P. Sokoloff, Proc. Natl. Acad. Sci. USA 89 8155- 8159 (1992).
25. R.J. Primus, A. Thurkauf, J. Xu, E. Yevich, S. McLnerney, K. Shaw, J.F. Tallman and D.W. Gallagher, J. Pharmacol. Exp. Ther. 282 1020-1027 (1997).
26. D.R. Sibley and K.A. Neve, The Dopamine Receptors, K.A. Neve and R.L. Neve (Eds), 383-424, Humana Press, Totowa (1997).
27. M.M. Bradford, Anal. Biochem. 72 248-254 (1976).
28. M.W. Hamblin, S.E. Leff and I. Creese, Biochem. Pharmacol. 33 877-887 (1984).
29. S. Lazareno and N.J.M. Birdsall, Br. J. Pharmacol. 109 1110-1119 (1993).
30. P. Seeman, Psychopharmacology : The Fourth Generation of Progress, F.E. Bloom and D.J. Kupfer (Eds), 295-302, Raven Press, New York (1995).
31. P.W. Baures, W.H. Ojala, W.B. Gleason, R.K. Mishra and R.L. Johnson, J. Med. Chem. 37 3677-3683 (1994).
32. S. Lazareno, Methods in Molecular Biology, Vol. 83 : Receptor Signal Transduction Protocols, R.A.J. Challiss (Ed), 107-116, Humana Press, Totowa (1997).
33. M. Watanabe, S.R. George and P. Seeman, Biochem. Pharmacol. 34 2459-2463 (1985).
34. E. Werle, T. Lenz, G. Strobel and H. Weicker, Naunyn-Schmiedeberg's Arch. Pharmacol. 338 28-34 (1988).
35. G. Schettini, C. Ventra, T. Florio, M. Grimaldi, O. Meucci and A. Marino, J. Neurochem. 59 1667-1674 (1992).
36. A.N. Lieberman and M. Goldstein, Pharmacol. Rev. 37 217-227 (1985).
37. W.M. McDonald, D.R. Sibley, B.F. Kilpatrick and M.G. Caron, Mol. Cell. Endocrinol. 36 201-209 (1984).
38. I.D. Adapa and L. Toll, Neuropeptides 31 403-408 (1997).
39. E.R. Marcotte and R.K. Mishra, Neuromethods, Vol. 31 : G Protein Methods and Protocols, R.K. Mishra, G.B. Baker and A.A. Boulton (Eds), 139-161, Humana Press, Totowa (1997).
40. P.H. Andersen and J.A. Jansen, Eur J. Pharmacol. Mol. Pharmacol. Sec. 188, 335-347 (1990).
41. J. Arnt, J. Hyttel, C. Sanchez, Eur. J. Pharmacol. 213 259-267 (1992).
42. A.S. Undie, J. Weinstock, H.M. Sarau and E. Friedman, J. Neurochem. 62 2045- 2048 (1994).
43. S.J. Vyas, J. Eichberg and M.F. Lokhandwala, J. Pharmacol. Exp. Ther. 260 134- 139 (1992).
44. P.M. Beart, D. McDonald, M. Cincotta, D.J. De Vries and A.L. Gundlach, Gen. Pharmacol. 17 57-62 (1986).
45. J.H. Boublik and J.W. Funder, Eur. J. Pharmacol. 107 11-16 (1984).
46. G.A. McPherson and P.M. Beart, Eur. J. Pharmacol. 91 363-369 (1983).
47. M. Miyagi, F. Itoh, F. Taya, N. Arai, M. Isaji, M. Kojima and A. Ujiie, Biol. Pharm. Bull. 19 1210-1213 (1996).
48. E.C. Akam, A.M. Carruthers, S.R. Nahorski and R.A.J. Challiss, Br. J. Pharmacol. 121 1203-1209 (1997).
49. F. Okada, A. Ito, T. Horikawa, Y. Tokumitsu and Y. Nomura, Neurochem. Int. 28 161-168 (1996).
50. D.A. Staunton, B.B. Wolfe, P.M. Groves and P.B. Molinoff, Brain Res. 211 315- 327 (1981).
51. M. Memo, M. Pizzi, E. Nisoli, C. Missale, M.O. Carruba and P. Spano, Eur. J. Pharmacol. 138 45-51 (1987).